Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RZLT
RZLT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RZLT News
Faruqi & Faruqi Investigates Rezolute Losses for Investors
6h ago
Globenewswire
Faruqi & Faruqi Investigates Investor Losses in Rezolute
2d ago
PRnewswire
Rezolute Reports Q2 Loss, Downgrades Ahead
3d ago
seekingalpha
Rezolute Shares Plunge 90% After Phase 3 Trial Failure
6d ago
Globenewswire
Faruqi & Faruqi Investigates Losses in Rezolute Stock
Feb 07 2026
PRnewswire
Faruqi & Faruqi Investigates Rezolute Losses
Feb 04 2026
Globenewswire
Faruqi & Faruqi Investigates Investor Losses in Rezolute
Jan 29 2026
PRnewswire
Faruqi & Faruqi Encourages Rezolute Investors to Discuss Legal Options
Jan 26 2026
PRnewswire
Faruqi & Faruqi Investigates Rezolute Loss Claims After Disappointing Trial Results
Jan 23 2026
Globenewswire
Rezolute, Inc. Under Investigation for Securities Fraud as Stock Plummets 87.2%
Jan 20 2026
Globenewswire
Faruqi & Faruqi Investigates Investor Losses in Rezolute (NASDAQ:RZLT)
Jan 17 2026
PRnewswire
Rezolute, Inc. (RZLT) Shares Plunge 90% After Phase 3 Trial Failure Sparks Investigation
Jan 14 2026
PRnewswire
Rezolute, Inc. Under Investigation Amid 87.2% Stock Price Drop Following Phase 3 Study Results
Jan 13 2026
Globenewswire
Faruqi & Faruqi Investigates Potential Claims Against Rezolute After Stock Plunge
Jan 08 2026
Globenewswire
Rezolute, Inc. Faces Investigation After 87.2% Stock Drop Following Phase 3 Study Results
Jan 08 2026
PRnewswire
Rezolute Shares Phase 3 sunRIZE Data on Ersodetug, Plans FDA Meeting
Jan 07 2026
Globenewswire
Show More News
